title: Short- and long-term prognostic implications of in-hospital postinfarction arrhythmias. DAVIT II Study Group.
abstract: The purpose of the present study was to evaluate, in patients surviving the first postinfarction week, the short- and long-term prognostic implications of arrhythmias, and their relation to easily obtained anamnestic and clinical parameters presented during hospitalisation. The study consisted of 897 placebo-treated patients of the Danish Verapamil Infarction Trial II (DAVIT II). In patients with and without supraventricular tachycardia mortality within 2 months was 9.2 and 3.7% (p = 0.004), respectively. By multivariate analysis supraventricular tachycardia independently predicted mortality within 2 months. Mortality within 5 years was predicted by the presence of supraventricular tachycardia, atrial fibrillation, advanced atrioventricular block, sinoatrial block, and of the combined arrhythmic parameter, i.e. ventricular and/or atrial fibrillation and/or advanced atrioventricular block. When easily obtained and assessed anamnestic and clinical parameters were included in a multivariate analysis, the presence of supraventricular tachycardia alone gave independent prognostic information on long-term mortality.
authors.affiliation: Department of Internal Medicine B, County Hospital, Hillerød, Denmark.
authors.forename: M
authors.initials: M
authors.lastname: Vaage-Nilsen
authors.forename: J F
authors.initials: JF
authors.lastname: Hansen
authors.forename: K
authors.initials: K
authors.lastname: Mellemgaard
authors.forename: L
authors.initials: L
authors.lastname: Hagerup
authors.forename: B
authors.initials: B
authors.lastname: Sigurd
authors.forename: E
authors.initials: E
authors.lastname: Steinmetz
mesh_terms: D000368:Aged; D001145:Arrhythmias, Cardiac / Q000150:complications* / Q000188:drug therapy / Q000401:mortality; D006801:Humans; D015999:Multivariate Analysis; D009203:Myocardial Infarction / Q000150:complications* / Q000188:drug therapy; D011379:Prognosis; D014700:Verapamil / Q000627:therapeutic use
chemical_list: D014700:Verapamil